Latest Bioprocessing Stories
Summit features an expanded roster of meetings with increased formulation foci plus new meetings delving into early IND strategies and biomanufacturing. Needham, Mass. (PRWEB) May 16, 2013 Cambridge Healthtech Institute will host its fifth annual The Bioprocessing Summit from August 19-23, 2013 at the Renaissance Waterfront Hotel in Boston, MA. The ten meetings comprising the Summit provide a close-up look at the current strategies and innovations for optimizing bioprocesses while...
DUBLIN, March 14, 2013 /PRNewswire/ -- Research and Markets has announced the addition of the "Strategic Review of Corn Starch Industry & Markets - Starch, Sweeteners, Bioprocessing & Co-Products 2012" [http://www.researchandmarkets.com/research/bw99t7/strategic_review ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Comprehensive newly revised starch, sweeteners, ethanol, bioprocessing, bioplastic, co-products...
FRANKLIN LAKES, N.J., Nov. 7, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $1.967 billion for the fourth fiscal quarter ended September 30, 2012, representing a decrease of 1.1 percent from the prior-year period, or an increase of 4.7 percent on a foreign currency-neutral basis. For the full fiscal year ended September 30, 2012, BD reported revenues of $7.708 billion,...
FRANKLIN LAKES, N.J., Aug. 2, 2012 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $1.981 billion for the third fiscal quarter ended June 30, 2012, representing an increase of 1.5 percent from the prior-year period, or 4.9 percent on a foreign currency-neutral basis. "We are very pleased with our third quarter results," said Vincent A. Forlenza, Chairman of the Board, Chief...
SAN DIEGO, April 24, 2012 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that the Company is a sponsor and scheduled presenter at the upcoming 2012 BIO World Congress on Industrial Biotechnology and Bioprocessing. The conference is taking place April 29 - May 2, 2012 at the Gaylord Palms Resort and Convention Center in Orlando, Florida. James...
DUBLIN, March 27, 2012 /PRNewswire/ -- The Irish National Institute for Bioprocessing Research and Training (NIBRT) and Waters® Corporation (NYSE: WAT) announced today they have formed a multi-level partnership designed to support advanced concepts and deliver the promise of more effective biotherapeutic innovations addressing the world's most challenging diseases through both training and research. (Logo: http://photos.prnewswire.com/prnh/20110707/NE31586LOGO ) Waters and...
MILFORD, Mass., Jan. 20, 2012 /PRNewswire/ -- Waters Corporation (WAT:NYSE) and Ireland's National Institute for Bioprocessing Research and Training (NIBRT) announced today the availability of the world's first database for glycan analysis by UltraPerformance Liquid Chromatography® (UPLC®). Developed by Professor Pauline Rudd's research team at NIBRT, the new GlycoBase 3+ Database is the first-of-its-kind repository of chromatographic retention positions expressed in...
MARLBOROUGH, Mass., June 27, 2011 /PRNewswire/ -- Qteros, Inc., the developer of a unique and highly efficient Consolidated Bioprocessing (CBP) platform for the lowest-cost production of cellulosic ethanol, and the University of Massachusetts Amherst, today announced two significant intellectual property (IP) advances that extend the patent estate for their unique ethanol-producing microorganism, Clostridium phytofermentans, also known as the Q Microbe®. The United States Patent and...
By Jessica Nimon, International Space Station Program Science Office, NASA's Johnson Space Center The very idea of spiders in space brings to mind campy, black and white horror films involving eight-legged monsters. In actuality, it is a scientific investigation called Commercial Generic Bioprocessing Apparatus Science Insert-05 or CSI-05, in which researchers observe arachnid habits in a microgravity environment. This is the second spider investigation on the International Space...
MARLBOROUGH, Mass., April 28, 2011 /PRNewswire/ -- Qteros, Inc., the developer of a unique and highly efficient Consolidated Bioprocessing (CBP) platform for the lowest-cost production of cellulosic ethanol, today announced its plans to present at various industry conferences throughout the month of May. Kevin A. Gray, Ph.D., Senior Vice President and Chief Scientific Officer for Qteros, will deliver an oral presentation at the 33rd Symposium on Biotechnology for Fuels and Chemicals being...
